Cargando…
Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study
BACKGROUND: Levosimendan can improve clinical symptoms and the cardiorenal rescue success rate, and stabilize hemodynamic parameters in individuals suffering from acute decompensated heart failure. In addition, Shenfu injection (SFI) has been shown to protect the ischemic heart and enhance myocardia...
Autores principales: | Li, Miaomiao, Zhang, Yue, Wan, Qianli, Li, Yiou, Qu, Tianzhen, Yuan, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966164/ https://www.ncbi.nlm.nih.gov/pubmed/35350988 http://dx.doi.org/10.1186/s12872-022-02572-2 |
Ejemplares similares
-
Shenfu Injection for Intradialytic Hypotension: A Systematic Review and Meta-Analysis
por: Mo, Yenan, et al.
Publicado: (2014) -
A Critical Overview of Systematic Reviews of Shenfu Injection for Heart Failure
por: Huang, Jinke, et al.
Publicado: (2021) -
Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure
por: Zhou, Wei, et al.
Publicado: (2022) -
Chinese Medicine Shenfu Injection for Heart Failure: A Systematic Review and Meta-Analysis
por: Wen-Ting, Song, et al.
Publicado: (2012) -
Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway
por: Ni, Jingyu, et al.
Publicado: (2017)